bergenin has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, N; Acharya, S; Barai, P; Bhatt, H; Borisa, A; Raval, N | 1 |
| Kashima, Y; Miyazawa, M | 1 |
2 other study(ies) available for bergenin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
Topics: Acetylcholinesterase; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Benzopyrans; Brain; Butyrylcholinesterase; Cell Line; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Maze Learning; Memory Disorders; Molecular Docking Simulation; Neurons; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Streptozocin | 2019 |
Structure-activity relationships for bergenin analogues as β-secretase (BACE1) inhibitors.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Antioxidants; Aspartic Acid Endopeptidases; Benzoic Acid; Benzopyrans; Dose-Response Relationship, Drug; Molecular Targeted Therapy; Oxidative Stress; Protease Inhibitors; Reactive Oxygen Species; Saxifragaceae; Structure-Activity Relationship | 2013 |